In 1923, Kimball and Murlin published work that identified a substance in pancreatic extracts that caused hyperglycaemia, which they named glucagon. A century later, we now know the importance of this hormone in human physiology and disease, and drugs targeting the glucagon receptor family have been developed to treat metabolic diseases.